| Generic/working name | Pembrolizumab |
| Company name | Merck & Co. |
| Drug type | Antibody |
| Drug class | Immune therapy |
| Dose | 200 mg per flat dose |
| Unit | Milligrams |
| Route | Intravenous |
| Schedule of administration | Q3W |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.